At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 55 enrolled
Drug / intervention
RF Ablation procedureprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multi-Array Ablation of the Pulmonary Veins for Paroxysmal Atrial Fibrillation
In Brief
A Phase 4 clinical trial evaluating RF Ablation procedure for Paroxysmal Atrial Fibrillation. Completed, enrolled 55 participants across 5 sites in 4 countries.
Detailed Summary
The purpose of this trial was to investigate and confirm the safety, efficacy, and efficiency of the Ablation Frontiers® Cardiac Ablation System when used in the treatment of paroxysmal atrial fibrillation. (PAF)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParoxysmal Atrial Fibrillation
CountriesDenmark, Germany, Netherlands, Switzerland
CollaboratorsMedtronic
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2007
First PostedSep 2008
Primary CompletionSep 2009
Study CompletionJul 2011
TodayJul 2026
First PostedSep 1, 2008
Enrollment StartOct 1, 2007
Primary CompletionSep 1, 2009
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 17.8 years ago
Interventions
RF Ablation procedureprocedure
Patients with a history of symptomatic paroxysmal (self-terminating) AF and meeting all inclusion/exclusion criteria, as identified by the clinical investigator, will be enrolled in the study.